Aneurismal subarachnoid hemorrhage during the COVID-19 outbreak in a Hub and Spoke system: observational multicenter cohort study in Lombardy, Italy - Takeaways - MDSpire

Aneurismal subarachnoid hemorrhage during the COVID-19 outbreak in a Hub and Spoke system: observational multicenter cohort study in Lombardy, Italy

  • By

  • Alessandro Fiorindi

  • Marika Vezzoli

  • Francesco Doglietto

  • Luca Zanin

  • Giorgio Saraceno

  • Edoardo Agosti

  • Antonio Barbieri

  • Silvio Bellocchi

  • Claudio Bernucci

  • Daniele Bongetta

  • Andrea Cardia

  • Emanuele Costi

  • Marcello Egidi

  • Antonio Fioravanti

  • Roberto Gasparotti

  • Carlo Giussani

  • Gianluca Grimod

  • Nicola Latronico

  • Davide Locatelli

  • Dikran Mardighian

  • Giovanni Nodari

  • Jacopo Carlo Poli

  • Frank Rasulo

  • Elena Roca

  • Giovanni Marco Sicuri

  • Giannantonio Spena

  • Roberto Stefini

  • Oscar Vivaldi

  • Cesare Zoia

  • Stefano Calza

  • Marco Maria Fontanella

  • Marco Cenzato

  • October 25, 2021

  • 0 min

Share

  • 1

    Aneurismal subarachnoid hemorrhage (aSAH) is a time-sensitive neurosurgical emergency requiring prompt diagnosis and treatment.

  • 2

    During the COVID-19 pandemic, Lombardy implemented a Hub and Spoke system to centralize aSAH treatment in designated hospitals.

  • 3

    The study found a significant increase in diagnostic delay for aSAH during the COVID-19 period compared to pre-pandemic.

  • 4

    Only 5.5% of patients diagnosed with aSAH during COVID-19 tested positive for SARS-CoV-2, indicating low infection rates among this group.

  • 5

    No significant differences were observed in Fisher and WFNS grades between aSAH patients during the COVID-19 period and the pre-pandemic group.

Original Source(s)

Related Content